Denali Therapeutics (DNLI) 2025 Conference Transcript

Denali Therapeutics (DNLI) 2025 Conference September 03, 2025 02:45 PM ET Company ParticipantsJosh Schimmer - Managing DirectorRyan Watts - Co-Founder, President, CEO & DirectorJosh SchimmerI think we're ready to get started. Welcome, everyone. I'm Josh Schimmer from the Cantor Biotech Equity Research team. Very pleased to introduce Ryan Watts, Chief Executive Officer of Denali Therapeutics. Ryan, welcome.Ryan WattsGreat to be here.Josh SchimmerYou've got a lot going on, but I think the most pressing update ...